Bushcraft and ABI rehab at Calvert Reconnections
In Calvert Reconnections’ latest video, Senior Rehab Coach Rob Smith [...]
Your NR Headlines: Wednesday 14 February
Welcome to your daily round-up of everything happening in the world of neurorehabilitation.
Research developments
Interferon-gamma drives brain pathology in multiple system atrophy In a new study, researchers have used a mouse model and genetic and pharmacological approaches to show that IFNγ is produced primarily by infiltrating CD4+ T-cells and that IFNγ mediates the mechanisms that drive multiple system atrophy.
Your NR Headlines: Tuesday 13 February
Welcome to your daily round-up of everything happening in the world of neurorehabilitation.
Research developments
New glove improves muscle spasm recovery after stroke A glove-like wearable medical device has been designed by Stanford University and the Georgia Institute of Technology that aims to help with muscle spasms following a stroke. The team have said the glove achieves results that are as good or better than current treatments.
Your NR Headlines: Monday 12 February
Welcome to your daily round-up of everything happening in the world of neurorehabilitation.
Research developments
Speeding up Parkinson's diagnosis Researchers have developed a new a molecular assay test technique that may lead to the development of tests that can diagnose Parkinson’s at an early stage, as well as potentially leading to the development of new treatments.
Patients and professionals discuss benefits of canoeing and kayaking on brain injury rehab
In the second in a new series of videos, clinicians, [...]
Cambridgeshire rehab centre sets new standard for green energy use and sustainability
In an era where environmental consciousness is not just valued [...]
Study sheds light on how physical exercise improves mood
New findings may pave the way for the development of [...]
St Andrew’s Healthcare: Extending highly specialist neurobehavioural care
As the creator of Kemsley, the UK’s first specialist neurobehavioural [...]
Interview: Advances and challenges in Motor Neurone Disease research
With Motor Neurone Disease affecting more than 5,000 adults in the UK and survival rates on average of 18 months, there is an urgent need to find new treatment options. In this article, we sat down with Dr Brian Dickie, director of research development at the MND Association, which has just announced a £5 million funding injection to enable more patients take part in vital clinical trials. He shares his insights on the current state of research into MND and how the funding hopes to advance this. Unlock this article to read the full interview and learn more about: - Promising lines of investigation and potential treatment pathways for MND - How gene therapy is leading to some "never seen before" results - The role AI can play in helping to manage the condition
